Is a 76-year-old woman with congestive heart failure on carvedilol, a multinodular goitre treated with carbimazole, suppressed TSH and low‑normal T3, fit for elective hip surgery in three days?

This patient is NOT fit for elective hip surgery in 3 days and should be delayed until thyroid function is optimized and cardiac status is stabilized.

Critical Issues Requiring Preoperative Optimization

This 76-year-old woman presents with multiple high-risk features that make proceeding with surgery in 3 days unsafe:

1. Uncontrolled Subclinical/Overt Hyperthyroidism

• Suppressed TSH with multinodular goiter indicates active hyperthyroidism despite carbimazole treatment
• The combination of elderly age (>65 years), pre-existing CHF, and hyperthyroidism creates substantial perioperative cardiac risk 1, 2, 3
• Hyperthyroidism directly exacerbates heart failure through increased cardiac workload, tachycardia risk, and potential for atrial fibrillation 3, 4

2. Inadequate Cardiac Preparation

Beta-blockade is mandatory but insufficient alone in this scenario. While she's on carvedilol for CHF, guidelines specifically state that elderly patients with cardiovascular disease and hyperthyroidism require both beta-blockade AND achievement of euthyroid status before elective procedures 2.

The 2011 ATA/AACE guidelines explicitly recommend: "Patients with TMNG or TA who are at increased risk for complications due to worsening of hyperthyroidism, including the elderly and those with cardiovascular disease, should be treated with beta-blockade prior to radioactive iodine therapy and until euthyroidism has been achieved" 2. This same principle applies to surgical preparation.

3. Timing Considerations

Three days is grossly insufficient for:

• Optimizing thyroid function (typically requires weeks to months of antithyroid drug adjustment) 5
• Ensuring cardiac compensation is maximized
• Assessing response to increased carbimazole dosing

Recommended Preoperative Management Algorithm

Step 1: Immediate Thyroid Optimization (2-4 weeks minimum)

• Increase carbimazole dose to achieve blocking dose (30 mg daily) 5
• Recheck thyroid function (TSH, free T4, free T3) in 3-4 weeks 5
• Target: normalized free T4 and T3 levels before surgery

Step 2: Cardiac Risk Stratification

• Ensure carvedilol is at target dose for heart failure management 6, 7
• Assess for signs of decompensated CHF (weight gain, worsening dyspnea, edema)
• The 2024 AHA/ACC perioperative guidelines emphasize that patients with active HF symptoms are at significantly higher risk than those with compensated HF 8
• Consider echocardiography to assess current cardiac function

Step 3: Monitor for Hyperthyroidism-Related Cardiac Complications

Key risks in elderly patients with CHF and hyperthyroidism include:

• Atrial fibrillation (already present in many cases) 9, 10
• Tachycardia-induced cardiomyopathy 3
• Acute decompensated heart failure 4, 11
• Rare but reported: atrioventricular blocks 10

Step 4: Definitive Thyroid Treatment Consideration

Given her large multinodular goiter and cardiovascular disease, definitive treatment should be considered:

• First-line: Radioactive iodine (I-131) after medical control of thyrotoxicosis 1, 9
• Alternative: Total thyroidectomy if compression symptoms or I-131 contraindicated 1
• Long-term low-dose carbimazole is acceptable if definitive treatment refused, but requires ongoing monitoring 1, 9

Common Pitfalls to Avoid

1. Assuming beta-blockade alone is sufficient protection - It is not in elderly patients with cardiovascular disease and active hyperthyroidism 2

2. Proceeding with "urgent" orthopedic surgery without thyroid optimization - Hip surgery is rarely so urgent that 2-4 weeks of medical optimization cannot be achieved. The perioperative mortality risk in uncontrolled hyperthyroidism with CHF far exceeds the risk of delaying elective orthopedic surgery.

3. Failing to recognize that carvedilol should NOT be abruptly discontinued perioperatively - The FDA label explicitly warns against abrupt withdrawal, which can lead to clinical deterioration 7. Continue carvedilol through the perioperative period unless specific contraindications arise 8, 6.

4. Underestimating the cardiovascular stress of hyperthyroidism in the elderly - Studies show that hyperthyroidism is a chief cause of death in older patients when cardiovascular complications are not promptly recognized and managed 3

Specific Timeline Recommendation

Minimum delay: 3-4 weeks to allow:

• Thyroid function optimization with adjusted carbimazole dosing
• Confirmation of euthyroid status with repeat labs
• Cardiac compensation assessment
• Consideration of definitive thyroid treatment if recurrent hyperthyroidism is likely

Proceed to surgery only when:

• Free T4 and T3 are normalized
• TSH may still be suppressed (acceptable if free hormones normal)
• CHF is compensated (no weight gain, stable symptoms)
• Patient is on optimized beta-blocker therapy
• Anesthesia team is aware of thyroid and cardiac history

The evidence strongly supports that achieving euthyroid status before elective surgery in elderly patients with cardiovascular disease significantly reduces perioperative morbidity and mortality 1, 2, 3, 9.